Rx Medicare

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced, as part of its Phase 3 program, the initiation of a registration (also called pivotal) trial (Study 008) comparing efficacy and safety profiles of MoxDuo(TM)IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery…

Read More…

Related Posts

• QRxPharma Initiates Second Pivotal Phase 3 Study Of MoxDuo(TM)IR Dual-Opioid(TM) For NDA Submission
• QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study For MoxDuo(TM) IV Pain Therapy
• NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
• KAI Pharmaceuticals Initiates Third Phase 2a Study In Program To Develop KAI-1678 For The Treatment Of Neuropathic Pain
• QRxPharma Initiates Second Comparative Study For MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
• Cerimon Pharmaceuticals Initiates Phase III Clinical Studies To Evaluate Its Topical Diclofenac Sodium Patch For Mild-to-Moderate Pain
• ROXRO Announces FDA Accepts For Review NDA For ROX-888 For The Management Of Acute Moderate To Severe Pain
• Repros Thera. Announces That Proellex Significantly Reduced Pain In A U.S. Phase 2 Clinical Trial In Women With Moderate To Severe Endometriosis
• Zogenix Initiates Pivotal Phase 3 Clinical Trial For Novel Formulation Of Oral Controlled-Release Hydrocodone
• Spinal Restoration Initiates Patient Enrollment For Phase III Study Of Company’s Biostat(R) System
• Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal
• China Aoxing Pharmaceutical Company Announces Successful Completion Of Phase II Clinical Study Of Novel Menstrual Pain Drug
• Pacira’s Phase III Study Of EXPAREL(TM) Meets Primary Pain Relief Endpoint
• Nutra Pharma Announces Online Availability Of Cobroxin For The Treatment Of Moderate To Severe Chronic Pain
• Transdel Pharmaceuticals Announces Positive Phase 3 Study Results For Lead Topical Pain Drug Ketotransdel(R)

Tags: acute, initiates, moderate, moxduotmir, pain, phase, pivotal, qrxpharma, severe, study

This entry was posted on Tuesday, December 1st, 2009 at 9:12 pm and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.